Spots Global Cancer Trial Database for Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
Official Title: Phase II, Open Study, Exploratory Examination of Efficacy and Safety of Paricalcitol Injection and Maxacalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
Study ID: NCT00990704
Study Description
Brief Summary: This study is a exploratory comparison of the efficacy and safety of paricalcitol injection with maxacalcitol injection in chronic kidney disease participants receiving hemodialysis with secondary hyperparathyroidism.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Site Ref # / Investigator 53794, Anjo, , Japan
Site Ref # / Investigator 53787, Chiba, , Japan
Site Ref # / Investigator 53786, Kumagaya, , Japan
Site Ref # / Investigator 53792, Matsumoto, , Japan
Site Ref # / Investigator 53784, Mito, , Japan
Site Ref # / Investigator 53796, Nagasaki, , Japan
Site Ref # / Investigator 53795, Osaka, , Japan
Site Ref # / Investigator 21561, Sapporo, , Japan
Site Ref # / Investigator 53789, Tokyo, , Japan
Site Ref # / Investigator 53790, Tokyo, , Japan
Site Ref # / Investigator 53793, Toyohashi, , Japan
Site Ref # / Investigator 53785, Tsuchiura, , Japan
Site Ref # / Investigator 53788, Yachiyo, , Japan
Site Ref # / Investigator 53791, Yokosuka, , Japan
Contact Details
Name: Moriaki Kubo
Affiliation: Abbott Japan Co.,Ltd
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
